KRAS and ovarian carcinoma: These results were confirmed by performing ROC curve analysis which demonstrated that KRAS gene expression level exhibited excellent diagnostic value in distinguishing ovarian cancer patients from healthy controls (AUC 0.9, p = < 0.001).